首页> 外国专利> KIT FOR DETECTING PERIPHERAL BLOOD CIRCULATING TUMOR CELL PD-L1 GENE MUTATION OF PATIENT WITH KIDNEY CANCER, AND DETECTION METHOD

KIT FOR DETECTING PERIPHERAL BLOOD CIRCULATING TUMOR CELL PD-L1 GENE MUTATION OF PATIENT WITH KIDNEY CANCER, AND DETECTION METHOD

机译:用于检测肾癌患者外周血循环肿瘤细胞PD-L1基因突变的试剂盒,以及检测方法

摘要

Provided in the present invention are a kit for detecting a peripheral blood circulating tumor cell PD-L1 gene mutation of a patient with kidney cancer, and a detection method, which fall within the technical field of molecular biology. The kit comprises a diluent, a decolorizing solution, a staining solution A, a staining solution B, a PD-L1 (human) primary antibody, goat anti-human IgG/HRP antibody, 0.1% Triton X-100, 0.3% H2O2 and a 6×PBS buffer solution. By means of the detection method provided by the present invention, the PD-L1 expression of a patient with advanced or recurrent kidney cancer can be detected without acquiring a tissue specimen by means of needle biopsy. The technology is a minimally invasive technology, can realize real-time detection, can avoid false positive results caused by edge effects possibly generated in the staining process, has good stability, reduces cell loss and improves the accuracy of detection.
机译:本发明提供了一种用于检测患有肾癌患者的外周血循环肿瘤细胞PD-L1基因突变的试剂盒,以及落在分子生物学技术领域内的检测方法。 试剂盒包含稀释剂,脱色溶液,染色溶液A,染色溶液B,PD-L1(人)一抗,山羊抗人IgG / HRP抗体,0.1%Triton X-100,0.3%H 2 O 2和 6×PBS缓冲溶液。 通过本发明提供的检测方法,可以检测到具有晚期或复发性肾癌的患者的PD-L1表达,而无需通过针活检地获取组织样本。 该技术是一种微创技术,可以实现实时检测,可以避免伪阳性结果由可能在染色过程中产生的边缘效应,具有良好的稳定性,降低细胞损失并提高了检测的准确性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号